Banco Bilbao Vizcaya Argentaria, S.A. Novavax Inc Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $9.35 Billion
- Q4 2024
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Novavax Inc stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 60,508 shares of NVAX stock, worth $433,842. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60,508
Previous 77,607
22.03%
Holding current value
$433,842
Previous $980,000
50.41%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$113 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$84.9 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$79.9 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$55.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$41.5 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $561M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...